 The Indiana Department of Health is accepting grant applications for the distribution of opioid rescue kits that include Narcan (naloxone) nasal spray. The purpose of this grant is to provide the kits to local health departments (LHDs) for distribution in their communities. The services requested will be implemented during the anticipated period of May through September 2022. Applicants are encouraged to submit applications by April 15, 2022; applications beyond this date will be reviewed based on available funding. Respondents must be either local health departments or entities that serve Native American/Indigenous populations (including those who do not live on reservation land). Entities that disperse naloxone must be registered with optIN, the state’s naloxone entity website. Click here to register as a new entity. Recipients will be required to submit reports on June 30, 2022, and Sept. 30, 2022.
Click here to apply using REDCap.
 On March 15, the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), announced two grant programs totaling $25.6 million that will expand access to medication-assisted treatment (MAT) for opioid use disorder and prevent the misuse of prescription drugs.
This funding reflects the priorities of HHS’ Overdose Prevention Strategy, as well as its new initiative to strengthen the nation’s mental health and crisis care systems. The first grant program is the Strategic Prevention Framework for Prescription Drugs, which provides funds for state agencies, territories, and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant plan or a similar state plan to target prescription drug misuse. The second grant program is the Medication-Assisted Treatment – Prescription Drug and Opioid Addiction that provides resources to help expand and enhance access to medications for opioid use disorder (MOUD). Eligible applicants are domestic public and private non-profit entities, and the application due date is Friday, April 29, 2022. This program is expected to increase the number of individuals with Opioid Use Disorder (OUD) receiving MOUD, and decrease illicit opioid use and prescription opioid misuse, which has been a major issue in Indiana.
 Please visit the Indiana Drug Overdose Dashboard, where you will find data from 2017 up to provisional data for 2021. In this dashboard, you will find data regarding opioid prescriptions, hospital discharges, and drug-related deaths.
|
